Samimagham, Hamid Reza
Hassani Azad, Mehdi
Haddad, Maryam
Arabi, Mohsen
Hooshyar, Dariush
KazemiJahromi, Mitra
Funding for this research was provided by:
Hormozgan University of Medical Sciences
Article History
Received: 23 September 2020
Accepted: 24 September 2020
First Online: 13 October 2020
Ethics approval and consent to participate
: The protocol was approved by the ethics committee of Hormozgan University of Medical Sciences on August 2, 2020, with the code IR.HUMS.REC.1399.255. (ExternalRef removed)Authors certify that this trial has received ethical approval from the appropriate ethical committee as described above. Informed consent will be obtained in Persian language. where the harms and benefits of the oral Famotidine and the placebo were described.
: Not applicable.
: The authors declare that they have no competing interests.